Skip to main content
Top
Published in: BMC Nephrology 1/2013

Open Access 01-12-2013 | Research article

Factors associated with 24-hour urinary volume: the Swiss salt survey

Authors: Tobias Schoen, Jonas Blum, Fred Paccaud, Michel Burnier, Murielle Bochud, David Conen

Published in: BMC Nephrology | Issue 1/2013

Login to get access

Abstract

Background

Low 24-hour urine volume (24UV) may be a significant risk factor for decline in kidney function. We therefore aimed to study associated markers and possible determinants of 24UV in a sample of the Swiss population.

Methods

The cross-sectional Swiss Salt Study included a population-based sample of 1535 (746 men and 789 women) individuals from three linguistic regions of Switzerland. Data from 1300 subjects were available for the present analysis. 24UV was measured using 24-hour urine collection. Determinants of 24UV were identified using multivariable linear regression models.

Results

In bivariate analysis, 24UV was higher in women compared to men (2000 ml/24 h [interquartile range (IQR): 1354, 2562] versus 1780 ml/24 h [IQR: 1244, 2360], p = 0.002). In multivariable regression analyses, independent associated markers of 24UV were female sex (β = 280, 95% confidence interval [CI]: 174, 386, p < 0.0001), fluid intake (β = 604, 95% CI: 539, 670, p < 0.0001), sodium excretion (β = 4.2, 95% CI: 3.4, 4.9, p < 0.0001) age (β = 6.6, CI: 3.4, 9.7, p < .0001), creatinine clearance (β = 2.4, CI: 0.2, 4.6, p = 0.04), living in the German-speaking part of Switzerland (β = 124, CI: 29, 219, p = 0.01), alcohol consumption (β = 41, CI: 9, 73, p = 0.01 for increasing categories of alcohol consumption), body mass index (β = −32, CI: -45, -18, p < 0.0001), current smoking (β = −146, CI: -265, -26, p = 0.02), and consumption of meat and cold cut (β = −56, CI: -108, -5, p = 0.03).

Conclusion

In this large population-based, cross-sectional study, we found several strong and independent correlates for 24UV. These findings may be important to improve our understanding in the development of chronic kidney disease.
Literature
1.
go back to reference Jha V, Wang AY-M, Wang H: The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012, 27 (Suppl 3): iii32-iii38. Jha V, Wang AY-M, Wang H: The impact of CKD identification in large countries: the burden of illness. Nephrol Dial Transplant Off Publ Eur Dial Transpl Assoc - Eur Ren Assoc. 2012, 27 (Suppl 3): iii32-iii38.
2.
go back to reference Levey AS, Coresh J: Chronic kidney disease. Lancet. 2012, 379: 165-180. 10.1016/S0140-6736(11)60178-5.CrossRefPubMed Levey AS, Coresh J: Chronic kidney disease. Lancet. 2012, 379: 165-180. 10.1016/S0140-6736(11)60178-5.CrossRefPubMed
3.
go back to reference Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX: Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol CJASN. 2011, 6: 2634-2641. 10.2215/CJN.01990211.CrossRefPubMed Clark WF, Sontrop JM, Macnab JJ, Suri RS, Moist L, Salvadori M, Garg AX: Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol CJASN. 2011, 6: 2634-2641. 10.2215/CJN.01990211.CrossRefPubMed
4.
go back to reference Parks JH, Barsky R, Coe FL: Gender differences in seasonal variation of urine stone risk factors. J Urol. 2003, 170 (2 Pt 1): 384-388.CrossRefPubMed Parks JH, Barsky R, Coe FL: Gender differences in seasonal variation of urine stone risk factors. J Urol. 2003, 170 (2 Pt 1): 384-388.CrossRefPubMed
5.
go back to reference Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P: Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005, 67: 1934-1943. 10.1111/j.1523-1755.2005.00292.x.CrossRefPubMed Daudon M, Hennequin C, Boujelben G, Lacour B, Jungers P: Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int. 2005, 67: 1934-1943. 10.1111/j.1523-1755.2005.00292.x.CrossRefPubMed
6.
go back to reference Perucca J, Bouby N, Valeix P, Bankir L: Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R700-R705.CrossRefPubMed Perucca J, Bouby N, Valeix P, Bankir L: Sex difference in urine concentration across differing ages, sodium intake, and level of kidney disease. Am J Physiol Regul Integr Comp Physiol. 2007, 292: R700-R705.CrossRefPubMed
7.
go back to reference Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M: Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly. 2012, 142: 0-PubMed Guessous I, Dudler V, Glatz N, Theler JM, Zoller O, Paccaud F, Burnier M, Bochud M: Vitamin D levels and associated factors: a population-based study in Switzerland. Swiss Med Wkly. 2012, 142: 0-PubMed
8.
go back to reference Strippoli GFM, Craig JC, Rochtchina E, Flood VM, Wang JJ, Mitchell P: Fluid and nutrient intake and risk of chronic kidney disease. Nephrol Carlton Vic. 2011, 16: 326-334. 10.1111/j.1440-1797.2010.01415.x.CrossRef Strippoli GFM, Craig JC, Rochtchina E, Flood VM, Wang JJ, Mitchell P: Fluid and nutrient intake and risk of chronic kidney disease. Nephrol Carlton Vic. 2011, 16: 326-334. 10.1111/j.1440-1797.2010.01415.x.CrossRef
9.
go back to reference Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S: High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis Off J Natl Kidney Found. 2003, 41: 962-971. 10.1016/S0272-6386(03)00193-8.CrossRef Hebert LA, Greene T, Levey A, Falkenhain ME, Klahr S: High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis Off J Natl Kidney Found. 2003, 41: 962-971. 10.1016/S0272-6386(03)00193-8.CrossRef
10.
go back to reference Wenzel UO, Hebert LA, Stahl RAK, Krenz I: My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol CJASN. 2006, 1: 344-346. 10.2215/CJN.01140905.CrossRefPubMed Wenzel UO, Hebert LA, Stahl RAK, Krenz I: My doctor said I should drink a lot! Recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol CJASN. 2006, 1: 344-346. 10.2215/CJN.01140905.CrossRefPubMed
11.
go back to reference Torres VE, Bankir L, Grantham JJ: A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol CJASN. 2009, 4: 1140-1150. 10.2215/CJN.00790209.CrossRefPubMed Torres VE, Bankir L, Grantham JJ: A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol CJASN. 2009, 4: 1140-1150. 10.2215/CJN.00790209.CrossRefPubMed
12.
go back to reference Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012, 367: 2407-2418. 10.1056/NEJMoa1205511.CrossRefPubMedPubMedCentral Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS: Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012, 367: 2407-2418. 10.1056/NEJMoa1205511.CrossRefPubMedPubMedCentral
13.
go back to reference Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, Wallace DP: Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol JASN. 2006, 17: 2220-2227. 10.1681/ASN.2006030251.CrossRefPubMed Nagao S, Nishii K, Katsuyama M, Kurahashi H, Marunouchi T, Takahashi H, Wallace DP: Increased water intake decreases progression of polycystic kidney disease in the PCK rat. J Am Soc Nephrol JASN. 2006, 17: 2220-2227. 10.1681/ASN.2006030251.CrossRefPubMed
14.
go back to reference Wang X, Gattone V, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol JASN. 2005, 16: 846-851. 10.1681/ASN.2004121090.CrossRefPubMed Wang X, Gattone V, Harris PC, Torres VE: Effectiveness of vasopressin V2 receptor antagonists OPC-31260 and OPC-41061 on polycystic kidney disease development in the PCK rat. J Am Soc Nephrol JASN. 2005, 16: 846-851. 10.1681/ASN.2004121090.CrossRefPubMed
15.
go back to reference Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJC: Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol. 2013, 189: 935-939. 10.1016/j.juro.2012.08.254.CrossRefPubMed Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, Daudon M, Molinier L, Tack I, Nuijten MJC: Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol. 2013, 189: 935-939. 10.1016/j.juro.2012.08.254.CrossRefPubMed
16.
go back to reference Frassetto L, Kohlstadt I: Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011, 84: 1234-1242.PubMed Frassetto L, Kohlstadt I: Treatment and prevention of kidney stones: an update. Am Fam Physician. 2011, 84: 1234-1242.PubMed
17.
go back to reference Arnlöv J, Ingelsson E, Sundström J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010, 121: 230-236. 10.1161/CIRCULATIONAHA.109.887521.CrossRefPubMed Arnlöv J, Ingelsson E, Sundström J, Lind L: Impact of body mass index and the metabolic syndrome on the risk of cardiovascular disease and death in middle-aged men. Circulation. 2010, 121: 230-236. 10.1161/CIRCULATIONAHA.109.887521.CrossRefPubMed
18.
go back to reference Lakier JB: Smoking and cardiovascular disease. Am J Med. 1992, 93: 8S-12S. 10.1016/0002-9343(92)90620-Q.CrossRefPubMed Lakier JB: Smoking and cardiovascular disease. Am J Med. 1992, 93: 8S-12S. 10.1016/0002-9343(92)90620-Q.CrossRefPubMed
19.
go back to reference De Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR, Nettleton JA: Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2012, 96: 397-404. 10.3945/ajcn.112.037770.CrossRefPubMedPubMedCentral De Oliveira Otto MC, Mozaffarian D, Kromhout D, Bertoni AG, Sibley CT, Jacobs DR, Nettleton JA: Dietary intake of saturated fat by food source and incident cardiovascular disease: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2012, 96: 397-404. 10.3945/ajcn.112.037770.CrossRefPubMedPubMedCentral
20.
go back to reference Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S: Kidney stone disease and risk factors for coronary heart disease. Int J Urol Off J Jpn Urol Assoc. 2005, 12: 859-863. Hamano S, Nakatsu H, Suzuki N, Tomioka S, Tanaka M, Murakami S: Kidney stone disease and risk factors for coronary heart disease. Int J Urol Off J Jpn Urol Assoc. 2005, 12: 859-863.
21.
22.
go back to reference He FJ, Markandu ND, Sagnella GA, MacGregor GA: Effect of salt intake on renal excretion of water in humans. Hypertension. 2001, 38: 317-320. 10.1161/01.HYP.38.3.317.CrossRefPubMed He FJ, Markandu ND, Sagnella GA, MacGregor GA: Effect of salt intake on renal excretion of water in humans. Hypertension. 2001, 38: 317-320. 10.1161/01.HYP.38.3.317.CrossRefPubMed
23.
go back to reference Wang XM, Lemos JR, Dayanithi G, Nordmann JJ, Treistman SN: Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res. 1991, 551: 338-341. 10.1016/0006-8993(91)90954-T.CrossRefPubMed Wang XM, Lemos JR, Dayanithi G, Nordmann JJ, Treistman SN: Ethanol reduces vasopressin release by inhibiting calcium currents in nerve terminals. Brain Res. 1991, 551: 338-341. 10.1016/0006-8993(91)90954-T.CrossRefPubMed
24.
go back to reference Massey LK, Sutton RAL: Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol. 2004, 172: 555-558. 10.1097/01.ju.0000129413.87024.5c.CrossRefPubMed Massey LK, Sutton RAL: Acute caffeine effects on urine composition and calcium kidney stone risk in calcium stone formers. J Urol. 2004, 172: 555-558. 10.1097/01.ju.0000129413.87024.5c.CrossRefPubMed
25.
go back to reference Fiala J, Brázdová Z: A comparison between the lifestyles of men and women–parents of school age children. Cent Eur J Public Health. 2000, 8: 94-100.PubMed Fiala J, Brázdová Z: A comparison between the lifestyles of men and women–parents of school age children. Cent Eur J Public Health. 2000, 8: 94-100.PubMed
Metadata
Title
Factors associated with 24-hour urinary volume: the Swiss salt survey
Authors
Tobias Schoen
Jonas Blum
Fred Paccaud
Michel Burnier
Murielle Bochud
David Conen
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Nephrology / Issue 1/2013
Electronic ISSN: 1471-2369
DOI
https://doi.org/10.1186/1471-2369-14-246

Other articles of this Issue 1/2013

BMC Nephrology 1/2013 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.